SCHEMBL6709232

SCHEMBL6709232

N#Cc1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCc4cc(Cl)ccc43)c2)c(C(=O)Nc2nccs2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.51
GAA P10253 3/20 0.51
TSHR P16473 2/20 0.51
ALDH1A1 P00352 1/20 0.49
LMNA P02545 4/20 0.49
HTT P42858 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
NR3C1 P04150 1/20 0.48
AR P10275 1/20 0.48
MEN1 O00255 1/20 0.48
MAPK1 P28482 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
PPARG P37231 2/20 0.48
PPARD Q03181 2/20 0.48
PPARA Q07869 2/20 0.48
MAPT P10636 4/20 0.47
TP53 P04637 2/20 0.46
THRB P10828 1/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6350787 0.86 PPARG (0.63) LMNAHTTNR3C1ARMEN1
SCHEMBL6357250 0.84 MAPT (0.56) NR3C1ARMEN1KMT2APPARG
SCHEMBL6350657 0.81 PPARG (0.59) LMNAHTTNR3C1ARSMN1; SMN2
SCHEMBL6346501 0.79 PPARG (0.53) LMNAHTTNR3C1ARSMN1; SMN2
SCHEMBL6710185 0.78 MAPT (0.57) MEN1KMT2AMAPTTP53
SCHEMBL6358617 0.78 NR3C1 (0.67) GAAALDH1A1LMNAHTTNPSR1
SCHEMBL6348623 0.78 ALB (0.62) MEN1KMT2APPARGPPARDPPARA
SCHEMBL6346544 0.76 PPARG (0.66) LMNAHTTMEN1KMT2ASMN1; SMN2
SCHEMBL6707734 0.76 MAPT (0.61) MEN1KMT2ASMN1; SMN2MAPTTP53
SCHEMBL6351587 0.76 PPARG (0.59) LMNAHTTSMN1; SMN2PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 NPC1 3891/4885GAA 111/4885TSHR 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.